BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2910245)

  • 1. A comparison of palpable and nonpalpable breast cancers.
    Pagana TJ; Lubbe WJ; Schwartz SM; Sprechini GD
    Arch Surg; 1989 Jan; 124(1):26-8. PubMed ID: 2910245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid-hormone receptors in nonpalpable and more advanced stages of breast cancer. A contribution to the biology and natural history of carcinoma of the female breast.
    Tinnemans JG; Beex LV; Wobbes T; Sluis RF; Raemaekers JM; Benraad T
    Cancer; 1990 Sep; 66(6):1165-7. PubMed ID: 2400967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors affecting estrogen and progesterone receptors in primary breast cancer].
    Kuno K; Fukami A; Hori M; Kasumi F; Yoshimoto K
    Gan No Rinsho; 1983 May; 29(6):621-7. PubMed ID: 6876431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors.
    Stierer M; Rosen H; Weber R; Hanak H; Spona J; Tüchler H
    Ann Surg; 1993 Jul; 218(1):13-21. PubMed ID: 8328824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palpable breast cancers are inherently different from nonpalpable breast cancers.
    Skinner KA; Silberman H; Sposto R; Silverstein MJ
    Ann Surg Oncol; 2001 Oct; 8(9):705-10. PubMed ID: 11597010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation between estrogen and progesterone receptors and some clinical and pathological features in human breast cancer.
    Caldarola L; Volterrani P; Lai M; Vigezzi P; Gaglia P
    Ital J Surg Sci; 1985; 15(4):329-33. PubMed ID: 3830952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Androgen receptors in primary breast carcinoma. Relation to prognostic factors in comparison with estrogen and progesterone receptors].
    Reiner G; Jakesz R; Kolb R; Kühnl-Brady K; Reiner A; Schemper M; Spona J
    Dtsch Med Wochenschr; 1988 Jun; 113(22):892-7. PubMed ID: 3371221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytophotometrical and biochemical characterization of nonpalpable, mammographically detected mammary adenocarcinomas.
    Fallenius AG; Skoog LK; Svane GE; Auer GU
    Cytometry; 1984 Jul; 5(4):426-9. PubMed ID: 6468181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of the steroid receptor content in primary breast cancer.
    von Maillot K; Horke W; Prestele H
    Arch Gynecol; 1982; 231(3):185-90. PubMed ID: 7125700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and progesterone receptors as prognostic factors in early breast cancer.
    Saez S; Cheix F; Mayer M
    Recent Results Cancer Res; 1984; 91():192-8. PubMed ID: 6729216
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation of steroid receptors with histopathologic characteristics in breast carcinoma.
    Bhatavdekar JM; Trivedi SN; Shah NG; Karelia NH; Patel DD; Giri DD; Patel TB
    Neoplasma; 1988; 35(4):413-23. PubMed ID: 3185838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of histologically determined receptor state and the clinical course in tumors of the breast].
    Ghislandi E; Gottardi O
    Pathologica; 1985; 77(1049):323-35. PubMed ID: 3831883
    [No Abstract]   [Full Text] [Related]  

  • 14. [Correlation between receptor status histochemically determined and clinical course in tumors of the breast: execution and extension of the study].
    Gottardi O; Franchi L; Ghislandi E
    Pathologica; 1987; 79(1059-1060):141-7. PubMed ID: 3441404
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of progesterone receptors in primary breast cancer.
    Pichon MF; Pallud C; Brunet M; Milgrom E
    Recent Results Cancer Res; 1984; 91():186-91. PubMed ID: 6729215
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of estrogen and progesterone receptors in black and white breast cancer patients.
    Beverly LN; Flanders WD; Go RC; Soong SJ
    Am J Public Health; 1987 Mar; 77(3):351-3. PubMed ID: 3812846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone receptors and breast cancer: correlations with clinical and histologic features.
    Montesco MC; Pluchinotta A; Piffanelli A; Pelizzola D; Giovannini G; Pagnini CA
    Tumori; 1984 Oct; 70(5):445-50. PubMed ID: 6506229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multivariate analysis of the prognostic significance of pathological features in breast cancer of perimenopausal age.
    Betta PG; Robutti F; Spinoglio G; Bottero G
    Pathologica; 1988; 80(1067):287-92. PubMed ID: 3237437
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between steroid hormone receptors and prognostic factors in human breast cancer.
    Barbi GP; Marroni P; Bruzzi P; Nicolò G; Paganuzzi M; Ferrara GB
    Oncology; 1987; 44(5):265-9. PubMed ID: 3670793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.
    Tafra L; Essner R; Brenner RJ; Giuliano AE
    Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.